Results 101 to 110 of about 84,367,963 (213)

Colorectal cancer prevention in inflammatory bowel disease and the role of 5-aminosalicylic acid: a clinical review and update

open access: yes, 2008
A roundtable consensus meeting was held to consolidate current knowledge on the etiology of colorectal cancer in patients with inflammatory bowel disease and to review current strategies, both diagnostic and preventive, specifically addressing the role ...
Gasche, Christoph   +11 more
core   +1 more source

HYPERSENSITIVITY TO PARA-AMINOSALICYLIC ACID

open access: yes, 1965
1. Attention is drawn to the incidence of hypersensitivity to para-aminosalicylic acid in the course of antituberculous treatment. 2. The clinical features are described with particular reference to hepatic complications. 3.
H. E. D. Griffiths, C. Watts
core   +1 more source

Aminosalicylic Acid (Paser) [PDF]

open access: yes, 2016
This is a poster presented at the Natural Sciences Poster Session at Parkland College, which provides the chemical makeup, dosage, and the body\u27s response to Aminosalicylic Acid (Paser), a drug used with other medications for the treatment of ...
Vekaria, Vilas B
core  

A comparative study of the oxidation of 3-, 4- and 5-aminosalicylic acids at glassy carbon electrodes

open access: yes, 1998
The oxidation behavior of 3-aminosalicylic acid (3-ASA), 4-aminosalicylic acid (4-ASA) and 5-aminosalicyclic acid (5-ASA), the active part of the drugs Sulphasalazine and Dipentum for the treatment of ulcerative colitis, has been compared.
Nyholm, L,, Eriksson, A
core  

Multiparticulate systems containing 5-aminosalicylic acid for the treatment of inflammatory bowel disease

open access: yes, 2011
In recent years, many achievements have been realized in the therapy of inflammatory bowel disease (IBD) although its etiology remains unknown. Thus IBD treatment is symptomatic and targets general inflammatory mechanisms.
Rabišková, Miloslava   +5 more
core   +1 more source

Rectal 5-aminosalicylic acid induced pancreatitis in a patient with newly diagnosed ulcerative colitis

open access: yes
Rectal 5-aminosalicylic acid induced pancreatitis in a patient with newly diagnosed ulcerative ...
Jack Shembrey (19721461)   +3 more
core  

Para - Aminosalicylic Acid–Part iv

open access: yes, 1949
Summary After repeated exposure of M. tuberculosis H37RV to p-amino-salicylic acid for 10 months, no increase in resistance developed. Out of a total of 25 strains of M.
C L Goodacre, D E Seymour
core   +1 more source

Electroanalytical Overview: The Sensing of Mesalamine (5-Aminosalicylic Acid)

open access: yes
Mesalamine, known as 5-aminosalicylic acid, is a medication used primarily in the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.
Robert Crapnell (23881995)   +2 more
core  

Clinical evidence supporting the radical scavenger mechanism of 5-aminosalicylic acid

open access: yes, 1990
5-Aminosalicylic acid, the therapeutically active metabolite of sulfasalazine, was exposed to oxygen-derived free radicals produced by the Fenton reaction in vitro, and several metabolites were detected and characterized by high performance liquid ...
Riis, P   +5 more
core   +1 more source

NEW METABOLITES OF THE DRUG 5-AMINOSALICYLIC ACID .2. N-FORMYL-5-AMINOSALICYLIC ACID

open access: yes, 1991
1. A new metabolite of the drug 5-aminosalicylic acid (5-ASA) has been found in urine from pigs and in plasma of humans. The metabolite has been isolated from pig urine using an XAD-2 column and purified using preparative h.p.l.c. 2.
Tjornelund, J.   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy